Central neuregulin-1/ErbB signaling modulates cardiac function via sympathetic activity in pressure overload-induced heart failure

Journal of Hypertension

Volumn 32, Issue 4, 2014, Pages 817-825

  Matsukawa, Ryuichi ^a   Hirooka, Yoshitaka ^a   Ito, Koji ^a   Honda, Nobuhiro ^a   Sunagawa, Kenji ^a  

^a KYUSHU UNIVERSITY   (Japan)

Author keywords

Chronic heart failure; Neuregulin 1; Pressure overload; Sympathetic nervous system

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR 2; EPIDERMAL GROWTH FACTOR RECEPTOR 4; NEU DIFFERENTIATION FACTOR; NEU DIFFERENTIATION FACTOR BETA; NORADRENALIN; RECOMBINANT PROTEIN; UNCLASSIFIED DRUG; NRG1 PROTEIN, RAT; ONCOPROTEIN; EPIDERMAL GROWTH FACTOR RECEPTOR;

ABDOMINAL AORTA; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN STEM; CONTROLLED STUDY; DRUG MEGADOSE; ECHOCARDIOGRAPHY; HEART DILATATION; HEART FAILURE; HEART FUNCTION; HEART LEFT VENTRICLE DILATATION; HEART LEFT VENTRICLE ENDDIASTOLIC PRESSURE; HEART LEFT VENTRICLE FAILURE; HEART LEFT VENTRICLE HYPERTROPHY; HEART LEFT VENTRICLE OVERLOAD; LOW DRUG DOSE; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; SHAM PROCEDURE; SIGNAL TRANSDUCTION; SYMPATHETIC TONE; URINARY EXCRETION; URINE LEVEL; WISTAR KYOTO RAT; ADRENERGIC SYSTEM; ANIMAL; BLOOD PRESSURE; HEART; HEART LEFT VENTRICLE FUNCTION; HEMODYNAMICS; METABOLISM; PATHOPHYSIOLOGY; TIME; URINE; FOLLOW UP; HEART VENTRICLE ENDDIASTOLIC PRESSURE;

ANIMALS; AORTA, ABDOMINAL; BLOOD PRESSURE; BRAIN STEM; HEART; HEART FAILURE; HEMODYNAMICS; HYPERTROPHY, LEFT VENTRICULAR; MALE; NEUREGULIN-1; NOREPINEPHRINE; ONCOGENE PROTEINS V-ERBB; RATS; RATS, INBRED WKY; SIGNAL TRANSDUCTION; SYMPATHETIC NERVOUS SYSTEM; TIME FACTORS; VENTRICULAR DYSFUNCTION, LEFT;

EID: 84896317449     PISSN: 02636352     EISSN: 14735598     Source Type: Journal    
DOI: 10.1097/HJH.0000000000000072     Document Type: Article

References (42)

1. Mei L, Xiong WC. Neuregulin 1 in neural development, synaptic plasticity and schizophrenia. Nat Rev Neurosci 2008; 9:437-452
2. Melenhorst WB, Mulder GM, Xi Q, Hoenderop JG, Kimura K, Eguchi S, van Goor H. Epidermal growth factor receptor signaling in the kidney: Key roles in physiology and disease. Hypertension 2008; 52:987-993
3. Garratt AN, Ozcelik C, Birchmeier C. ErbB2 pathways in heart and neural diseases. Trends Cardiovasc Med 2003; 13:80-86
4. Pentassuglia L, Sawyer DB. The role of neuregulin-1beta/ErbB signaling in the heart. Exp Cell Res 2009; 315:627-637
5. Slamon DJ, Leyland-Jones B, Shak S, Fuchs H, Paton V, Bajamonde A, et al. Use of chemotherapy plus a monoclonal antibody against HER2 for metastatic breast cancer that overexpresses HER2. N Engl J Med 2001; 344:783-792
6. Seidman A, Hudis C, Pierri MK, Shak S, Paton V, Ashby M, et al. Cardiac dysfunction in the trastuzumab clinical trials experience. J Clin Oncol 2002; 20:1215-1221
7. Minami M, Matsumoto S, Horiuchi H. Cardiovascular side-effects of modern cancer therapy. Circ J 2010; 74:1779-1786
8. Crone SA, Zhao YY, Fan L, Gu Y, Minamisawa S, Liu Y, et al. ErbB2 is essential in the prevention of dilated cardiomyopathy. Nat Med 2002; 8:459-465
9. Garcia-Rivello H, Taranda J, Said M, Cabeza-Meckert P, Vila-Petroff M, Scaglione J, et al. Dilated cardiomyopathy in Erb-b4-deficient ventricular muscle. Am J Physiol Heart Circ Physiol 2005; 289:H1153-H1160
10. Lemmens K, Doggen K, De Keulenaer GW. Role of neuregulin-1/ErbB signaling in cardiovascular physiology and disease: Implications for therapy of heart failure. Circulation 2007; 116:954-960
11. Sawyer DB, Caggiano A. Neuregulin-1beta for the treatment of systolic heart failure. J Mol Cell Cardiol 2011; 51:501-505
12. Jiang Z, Zhou M. Neuregulin signaling and heart failure. Curr Heart Fail Rep 2010; 7:42-47
13. Rohrbach S, Yan X, Weinberg EO, Hasan F, Bartunek J, Marchionni MA, Lorell BH. Neuregulin in cardiac hypertrophy in rats with aortic stenosis. Differential expression of erbB2 and erbB4 receptors. Circulation 1999; 100:407-412
14. Rohrbach S, Niemann B, Silber RE, Holtz J. Neuregulin receptors erbB2 and erbB4 in failing human myocardium - depressed expression and attenuated activation. Basic Res Cardiol 2005; 100:240-249
15. Ky B, Kimmel SE, Safa RN, Putt ME, Sweitzer NK, Fang JC, et al. Neuregulin-1 beta is associated with disease severity and adverse outcomes in chronic heart failure. Circulation 2009; 120:310-317
16. Liu X, Gu X, Li Z, Li X, Li H, Chang J, et al. Neuregulin-1/erbB- activation improves cardiac function and survival in models of ischemic, dilated, and viral cardiomyopathy. J Am Coll Cardiol 2006; 48:1438-1447
17. Jabbour A, Gao L, Kwan J, Watson A, Sun L, Qiu MR, et al. A recombinant human neuregulin-1 peptide improves preservation of the rodent heart after prolonged hypothermic storage. Transplantation 2011; 91:961-967
18. Jabbour A, Hayward CS, Keogh AM, Kotlyar E, McCrohon JA, England JF, et al. Parenteral administration of recombinant human neuregulin-1 to patients with stable chronic heart failure produces favourable acute and chronic haemodynamic responses. Eur J Heart Fail 2011; 13:83-92
19. Gao R, Zhang J, Cheng L, Wu X, Dong W, Yang X, et al. A Phase II, randomized, double-blind, multicenter, based on standard therapy, placebo-controlled study of the efficacy and safety of recombinant human neuregulin-1 in patients with chronic heart failure. J Am Coll Cardiol 2010; 55:1907-1914
20. Leenen FH. Brain mechanisms contributing to sympathetic hyperactivity and heart failure. Circ Res 2007; 101:221-223
21. Kuramochi Y, Guo X, Sawyer DB. Neuregulin activates erbB2-dependent src/FAK signaling and cytoskeletal remodeling in isolated adult rat cardiac myocytes. J Mol Cell Cardiol 2006; 41:228-235
22. Zhao YY, Sawyer DR, Baliga RR, Opel DJ, Han X, Marchionni MA, Kelly RA. Neuregulins promote survival and growth of cardiac myocytes. Persistence of ErbB2 and ErbB4 expression in neonatal and adult ventricular myocytes. J Biol Chem 1998; 273:10261-10269
23. Lemmens K, Fransen P, Sys SU, Brutsaert DL, De Keulenaer GW. Neuregulin-1 induces a negative inotropic effect in cardiac muscle: Role of nitric oxide synthase. Circulation 2004; 109:324-326
24. Brero A, Ramella R, Fitou A, Dati C, Alloatti G, Gallo MP, Levi R. Neuregulin-1beta1 rapidly modulates nitric oxide synthesis and calcium handling in rat cardiomyocytes. Cardiovasc Res 2010; 88:443-452
25. Thompson M, Lauderdale S, Webster MJ, Chong VZ, McClintock B, Saunders R, Weickert CS. Widespread expression of ErbB2, ErbB3 and ErbB4 in nonhuman primate brain. Brain Res 2007; 1139:95-109
26. Li B, Woo RS, Mei L, Malinow R. The neuregulin-1 receptor erbB4 controls glutamatergic synapse maturation and plasticity. Neuron 2007; 54:583-597
27. Woo RS, Li XM, Tao Y, Carpenter-Hyland E, Huang YZ, Weber J, et al. Neuregulin-1 enhances depolarization-induced GABA release. Neuron 2007; 54:599-610
28. Matsukawa R, Hirooka Y, Nishihara M, Ito K, Sunagawa K. Neuregulin-1/ErbB signaling in rostral ventrolateral medulla is involved in blood pressure regulation as an antihypertensive system. J Hypertens 2011; 29:1735-1742
29. Guyenet PG. The sympathetic control of blood pressure. Nat Rev Neurosci 2006; 7:335-346
30. Hirooka Y, Sagara Y, Kishi T, Sunagawa K. Oxidative stress and central cardiovascular regulation. Circ J 2010; 74:827-835
31. Sved AF, Ito S, Sved JC. Brainstem mechanisms of hypertension: Role of the rostral ventrolateral medulla. Curr Hypertens Rep 2003; 5:262-268
32. Chow MK, Shao Q, Ren B, Leenen FH, Van Huysse JW. Changes in brain Na, K-ATPase isoform expression and enzymatic activity after aortic constriction. Brain Res 2002; 944:124-134
33. Phrommintikul A, Tran L, Kompa A, Wang B, Adrahtas A, Cantwell D, et al. Effects of a Rho kinase inhibitor on pressure overload induced cardiac hypertrophy and associated diastolic dysfunction. Am J Physiol Heart Circ Physiol 2008; 294:H1804-H1814
34. Ito K, Hirooka Y, Matsukawa R, Nakano M, Sunagawa K. Decreased brain sigma-1 receptor contributes to the relationship between heart failure and depression. Cardiovasc Res 2012; 93:33-40
35. Lemmens K, Segers VF, Demolder M, De Keulenaer GW. Role of neuregulin-1/ErbB2 signaling in endothelium-cardiomyocyte crosstalk. J Biol Chem 2006; 281:19469-19477
36. Carlsson T, Schindler FR, Hollerhage M, Depboylu C, Arias-Carrion O, Schnurrbusch S, et al. Systemic administration of neuregulin-1beta1 protects dopaminergic neurons in a mouse model of Parkinson's disease. J Neurochem 2011; 117:1066-1074
37. Kastin AJ, Akerstrom V, Pan W. Neuregulin-1-beta1 enters brain and spinal cord by receptor-mediated transport. J Neurochem 2004; 88:965-970
38. Matsukawa R, Hirooka Y, Ito K, Sunagawa K. Inhibition of neuregulin-1/ErbB signaling in the rostral ventrolateral medulla leads to hypertension through reduced nitric oxide synthesis. Am J Hypertens 2013; 26:51-57
39. Odiete O, Hill MF, Sawyer DB. Neuregulin in cardiovascular development and disease. Circ Res 2012; 111:1376-1385
40. AkersWS, Cross A, Speth R, Dwoskin LP, Cassis LA. Renin-angiotensin system and sympathetic nervous system in cardiac pressure-overload hypertrophy. Am J Physiol Heart Circ Physiol 2000; 279:H2797-H2806
41. Helies-Toussaint C, Moinard C, Rasmusen C, Tabbi-Anneni I, Cynober L, Grynberg A. Aortic banding in rat as a model to investigate malnutrition associated with heart failure. Am J Physiol Regul Integr Comp Physiol 2005; 288:R1325-R1331
42. Ganguly PK, Sherwood GR. Noradrenaline turnover and metabolism in myocardium following aortic constriction in rats. Cardiovasc Res 1991; 25:579-585